Phytochemical Name : Baneh extract

Properties Information
PhytoCAT-ID PhytoCAT-720
Phytochemical name or plant extracts Baneh extract
PMID 21818667
Literature evidence It is now widely accepted that dietary phytochemicals inhibit cancer progression and enhance the effects of conventional chemotherapy.
IUPAC name NA
Phytochemicals’ class or type of plant extracts Methanolic extract
Source of phytochemicals or plant Extracts Pistacia atlantica
Geographical availability Afghanistan, Algeria, Canary Is., Cyprus, East Aegean Is., Greece, Iran, Iraq, Krym, Lebanon-Syria, Libya, Morocco, North Caucasus, Pakistan, Palestine, Saudi Arabia, Sinai, Transcaucasus, Tunisia, Turkey, Turkey-in-Europe, West Himalaya
Plant parts Fruits skin
Other cancers Breast cancer
Target gene or protein Caspase 3, PARP, Cyclin D1, CDK4
Gene or Protein evidence Finally, molecular analysis of apoptosis by western blotting proved activation of caspase 3 followed by poly ADP ribose polymerase (PARP) cleavage more efficiently in Baneh than in Dox treated cancer cells. Taken together, our results establish that the antitumor activity of the pericarp extract of Baneh partly is mediated via cell cycle arrest and downregulation of cyclin D1 and cdk4 expression.
Target pathways NA
IC50 1 mg/ml against T47D
Potency These findings indicate that Baneh extract contains phytochemicals which act as inhibitor of cell proliferation and inducer of apoptosis in human breast cancer T47D cells that makes it a potentially good candidate for new anticancer drug development.
Cell line/ mice model T47D
Additional information  Analysis of Baneh-treated cells by flow cytometry and fluorescence microscopy indicated strong apoptosis induction and nuclear morphological alterations similar to or greater than Dox.
PubChem ID NA
Additional PMIDs 23351343 32184861
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:70236-1
Safety NA